Cargando…
Effect of Medicaid Coverage of Tobacco-Dependence Treatments on Smoking Cessation
Smoking cessation aids (nicotine replacement products and anti-depressant medication) have been proven to double quitting rates compared to placebo in several randomized controlled trials. But the high initial cost of cessation aids might create a financial barrier to cessation for low-income smoker...
Autor principal: | Liu, Feng |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800340/ https://www.ncbi.nlm.nih.gov/pubmed/20049252 http://dx.doi.org/10.3390/ijerph6123143 |
Ejemplares similares
-
Medicaid Coverage for Tobacco Dependence Treatments in Massachusetts and Associated Decreases in Smoking Prevalence
por: Land, Thomas, et al.
Publicado: (2010) -
State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Coverage — United States, 2008–2014
por: Singleterry, Jennifer, et al.
Publicado: (2014) -
Medicaid coverage for tobacco dependence treatment: Enrollee awareness and use
por: Hayes, Kim A., et al.
Publicado: (2021) -
State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments — United States, 2015–2017
por: DiGiulio, Anne, et al.
Publicado: (2018) -
State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments — United States, 2008–2018
por: DiGiulio, Anne, et al.
Publicado: (2020)